{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T08:29:54Z","timestamp":1772612994708,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,9,15]],"date-time":"2009-09-15T00:00:00Z","timestamp":1252972800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s10194-009-0151-1","type":"journal-article","created":{"date-parts":[[2009,9,14]],"date-time":"2009-09-14T09:57:07Z","timestamp":1252922227000},"page":"435-440","source":"Crossref","is-referenced-by-count":8,"title":["The central analgesia induced by antimigraine drugs is independent from Gi proteins: superiority of a fixed combination of indomethacin, prochlorperazine and caffeine, compared to sumatriptan, in an in vivo model"],"prefix":"10.1007","volume":"10","author":[{"given":"Carla","family":"Ghelardini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"Galeotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Vivoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Grazioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Uslenghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,15]]},"reference":[{"key":"151_CR1","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1212\/WNL.55.6.754","volume":"55","author":"SD Silberstein","year":"2000","unstructured":"Silberstein SD (2000) Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review). Neurology 55:754\u2013762 1:CAS:528:DC%2BD3cXntlygsLg%3D, 10993991","journal-title":"Neurology"},{"key":"151_CR2","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1046\/j.1526-4610.2003.03161.x","volume":"43","author":"V Monda Di","year":"2003","unstructured":"Di Monda V, Nicolodi M, Aloisio A, Del Bianco P, Fonzari M, Grazioli I, Uslenghi C, Vecchiet L, Sicuteri F (2003) Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine versus sumatriptan in the acute treatment of multiple migraine attacks: a multicenter, randomized, crossover trial. Headache 43:835\u2013844 10.1046\/j.1526-4610.2003.03161.x, 12940804","journal-title":"Headache"},{"issue":"8","key":"151_CR3","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/j.1742-1241.2007.01458.x","volume":"61","author":"G Sandrini","year":"2007","unstructured":"Sandrini G, Cerbo R, Del Bene E, Ferrari A, Genco S, Grazioli I, Martelletti P, Nappi G, Pinessi L, Sarchielli P, Tamburro P, Uslenghi C, Zanchin G (2007) Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, multicentre study. Int J Clin Pract 61(8):1256\u20131269 10.1111\/j.1742-1241.2007.01458.x, 1:CAS:528:DC%2BD2sXpvFSnurw%3D, 17627707","journal-title":"Int J Clin Pract"},{"issue":"10","key":"151_CR4","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/j.1468-1331.2005.01056.x","volume":"12","author":"R Cerbo","year":"2005","unstructured":"Cerbo R, Centonze V, Grazioli I, Tavolato B, Trenti T, Uslenghi C, Sternieri E (2005) Efficacy of a fixed combination of indomethacin, prochlorperazine, and caffeine in the treatment of episodic tension-type headache: a double-blind, randomized, nimesulide-controlled, parallel group, multicentre trial. Eur J Neurol 12(10):759\u2013767 10.1111\/j.1468-1331.2005.01056.x, 1:STN:280:DC%2BD2MrmtlGnsg%3D%3D, 16190913","journal-title":"Eur J Neurol"},{"key":"151_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0014-2999(94)90522-3","volume":"263","author":"XH Hu","year":"1994","unstructured":"Hu XH, Tang H, Li Q, Huang X (1994) Central mechanism of indomethacin analgesia. Eur J Pharmacol 263:53\u201357 10.1016\/0014-2999(94)90522-3, 1:CAS:528:DyaK2cXmsVKitLw%3D, 7821361","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"151_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S1043-6618(02)00126-3","volume":"46","author":"N Galeotti","year":"2002","unstructured":"Galeotti N, Ghelardini C, Grazioli I, Uslenghi C (2002) Indomethacin, caffeine and prochlorperazine alone and combined revert hyperalgesia in \u201cin vivo\u201d models of migraine. Pharmacol Res 46(3):245\u2013250 10.1016\/S1043-6618(02)00126-3, 1:CAS:528:DC%2BD38Xms1Ggsrc%3D, 12220967","journal-title":"Pharmacol Res"},{"issue":"8","key":"151_CR7","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jpain.2004.06.008","volume":"5","author":"C Ghelardini","year":"2004","unstructured":"Ghelardini C, Galeotti N, Grazioli I, Uslenghi C (2004) Indomethacin, alone and combined with prochlorperazine and caffeine, but not sumatriptan, abolishes peripheral and central sensitization in in vivo models of migraine. J Pain 5(8):413\u2013419 10.1016\/j.jpain.2004.06.008, 1:CAS:528:DC%2BD2cXovVKktbg%3D, 15501422","journal-title":"J Pain"},{"key":"151_CR8","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/j.1526-4610.2005.05153.x","volume":"45","author":"M Jakubowski","year":"2005","unstructured":"Jakubowski M, Levy D, Goor-Aryeh I, Collins B, Baywa Z, Burstein R (2005) Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1\/COX2 inhibitors. Headache 45:850\u2013861 10.1111\/j.1526-4610.2005.05153.x, 15985101","journal-title":"Headache"},{"key":"151_CR9","first-page":"342","volume":"49","author":"M Rasmussen","year":"2005","unstructured":"Rasmussen M (2005) Treatment of elevated intracranial pressure with indomethacin: friend or foe? Acta Anaesthesiol Scand 49:342\u2013350","journal-title":"Acta Anaesthesiol Scand"},{"key":"151_CR10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/ana.20763","volume":"59","author":"S Matharu","year":"2006","unstructured":"Matharu S, Cohen SA, Frackowiak RS, Goadsby PJ (2006) Posterior hypothalamic activation in paroxysmal hemicrania. Ann Neurol 59:535\u2013545 10.1002\/ana.20763, 16489610","journal-title":"Ann Neurol"},{"key":"151_CR11","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1046\/j.1468-2982.1998.1809622.x","volume":"18","author":"AE Castellano","year":"1998","unstructured":"Castellano AE, Micieli G, Bellantonio P, Buzzi MG, Marcheselli S, Pompeo F, Rossi F, Nappi G (1998) Indomethacin increases the effect of isosorbide dinitrate on cerebral hemodynamic in migraine patients: pathogenetic and therapeutic implications. Cephalalgia 18:622\u2013630 10.1046\/j.1468-2982.1998.1809622.x, 1:STN:280:DyaK1M%2FpsVWltA%3D%3D, 9876886","journal-title":"Cephalalgia"},{"key":"151_CR12","first-page":"252","volume":"165","author":"MG Buzzi","year":"1989","unstructured":"Buzzi MG, Sakas DE, Moskowitz MA (1989) Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura mater. Eur J Pharmacol 165:252\u2013258","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"151_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.phrs.2004.02.005","volume":"50","author":"C Ghelardini","year":"2004","unstructured":"Ghelardini C, Galeotti N, Uslenghi C, Grazioli I, Bartolini A (2004) Prochlorperazine induces central antinociception mediated by the muscarinic system. Pharmacol Res 50(3):351\u2013358 10.1016\/j.phrs.2004.02.005, 1:CAS:528:DC%2BD2cXlt1agtLc%3D, 15225680","journal-title":"Pharmacol Res"},{"issue":"15","key":"151_CR14","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.2165\/00002018-200124150-00004","volume":"24","author":"WY Zhang","year":"2001","unstructured":"Zhang WY (2001) A benefit-risk assessment of caffeine as an analgesic adjuvant. Drug Saf 24(15):1127\u20131142 10.2165\/00002018-200124150-00004, 1:CAS:528:DC%2BD38XitVKns7k%3D, 11772146","journal-title":"Drug Saf"},{"key":"151_CR15","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1007\/PL00005094","volume":"356","author":"C Ghelardini","year":"1997","unstructured":"Ghelardini C, Galeotti N, Bartolini A (1997) Caffeine induces central cholinergic analgesia. Naunyn\u2013Schmiedebergs Arch Pharmacol 356:590\u2013595 10.1007\/PL00005094, 1:CAS:528:DyaK2sXmvFeqtb4%3D, 9402038","journal-title":"Naunyn\u2013Schmiedebergs Arch Pharmacol"},{"key":"151_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1526-4610.1985.hed2506305.x","volume":"25","author":"RJ Mathew","year":"1985","unstructured":"Mathew RJ, Wilson WH (1985) Caffeine consumption, withdrawal and cerebral blood flow. Headache 25:305\u2013309 1:STN:280:DyaL28%2Fjt12msA%3D%3D, 4055363","journal-title":"Headache"},{"issue":"1","key":"151_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1046\/j.1468-2982.2001.00142.x","volume":"21","author":"N Galeotti","year":"2001","unstructured":"Galeotti N, Ghelardini C, Zoppi M, Del Bene E, Raimondi L, Beneforti E, Bartolini A (2001) Hypofunctionality of Gi proteins as aetiopathogenic mechanism for migraine and cluster headache. Cephalalgia 21(1):38\u201345 10.1046\/j.1468-2982.2001.00142.x, 1:STN:280:DC%2BD3M3htVWhtA%3D%3D, 11298662","journal-title":"Cephalalgia"},{"key":"151_CR18","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0014-2999(86)90240-2","volume":"124","author":"M Parenti","year":"1986","unstructured":"Parenti M, Tirone F, Giagnoni G, Pecora N, Parolaro D (1986) Pertussis toxin inhibits the antinociceptive action of morphine in the rat. Eur J Pharmacol 124:357\u2013359 10.1016\/0014-2999(86)90240-2, 1:CAS:528:DyaL28Xkslanurs%3D, 3732384","journal-title":"Eur J Pharmacol"},{"key":"151_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0014-2999(96)00299-3","volume":"308","author":"N Galeotti","year":"1996","unstructured":"Galeotti N, Ghelardini C, Bartolini A (1996) Effect of pertussis toxin on morphine, diphenhydramine, baclofen, clomipramine and physostigmine antinociception. Eur J Pharmacol 308:125\u2013133 10.1016\/0014-2999(96)00299-3, 1:CAS:528:DyaK28Xkt12rtbc%3D, 8840123","journal-title":"Eur J Pharmacol"},{"key":"151_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1476-5381.1957.tb01354.x","volume":"12","author":"TG Haley","year":"1957","unstructured":"Haley TG, McCormick GL (1957) Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br J Pharmacol Chemother 12:12\u201315 1:CAS:528:DyaG2sXlsl2lsw%3D%3D, 13413144","journal-title":"Br J Pharmacol Chemother"},{"key":"151_CR21","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0022-3565(25)21201-0","volume":"279","author":"C Ghelardini","year":"1996","unstructured":"Ghelardini C, Galeotti N, Figini M, Imperato A, Nicolodi M, Sicuteri F, Gessa GL, Bartolini A (1996) The central cholinergic system has a role in the antinocicetion induced in rodents and guinea pigs by the antimigraine drug sumatriptan. J Pharmacol Exp Ther 279:884\u2013890 1:CAS:528:DyaK28XntVansbs%3D, 8930196","journal-title":"J Pharmacol Exp Ther"},{"key":"151_CR22","first-page":"412","volume":"18","author":"R Koster","year":"1959","unstructured":"Koster R, Anderson M, De Beer EJ (1959) Acetic acid for analgesic screening. Fed Proc 18:412\u2013413","journal-title":"Fed Proc"},{"issue":"1","key":"151_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0091-3057(89)90458-9","volume":"33","author":"JA DeLeo","year":"1989","unstructured":"DeLeo JA, Colburn RW, Coombs DW, Ellis MA (1989) The differentiation of NSAIDs and prostaglandin action using a mechanical visceral pain model in the rat. Pharmacol Biochem Behav 33(1):253\u2013255 10.1016\/0091-3057(89)90458-9, 1:STN:280:DyaL1Mzoslamsg%3D%3D, 2780782","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"151_CR24","first-page":"192","volume":"10","author":"C Ghelardini","year":"1996","unstructured":"Ghelardini C, Galeotti N, Donaldson S, Nicolodi M, Sicuteri F, Bartolini A (1996) Prevention by sumatriptan of hyperalgesia induced by morphine withdrawal. Fundam Clin Pharmacol 10(2):192","journal-title":"Fundam Clin Pharmacol"},{"issue":"10","key":"151_CR25","first-page":"2298","volume":"28","author":"N Galeotti","year":"2001","unstructured":"Galeotti N, Ghelardini C, Zoppi M, Del Bene E, Raimondi L, Beneforti E, Alessandro A (2001) A reduced functionality of Gi proteins as a possible cause of fibromyalgia. J Rheumatol 28(10):2298\u20132304 1:CAS:528:DC%2BD3MXnvVCis7Y%3D, 11669173","journal-title":"J Rheumatol"},{"key":"151_CR26","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1468-2982.2005.01060.x","volume":"26","author":"G Ifergane","year":"2006","unstructured":"Ifergane G, Buskila D, Simiseshvely N, Zeev K, Cohen H (2006) Prevalence of fibromyalgia syndrome in migraine patients. Cephalalgia 26:451\u2013456 10.1111\/j.1468-2982.2005.01060.x, 1:STN:280:DC%2BD287mslansg%3D%3D, 16556247","journal-title":"Cephalalgia"},{"key":"151_CR27","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.pain.2004.05.009","volume":"110","author":"R Staud","year":"2004","unstructured":"Staud R, Price DD, Robinson ME, Mauderli AP, Vierck CJ (2004) Maintenance of windup of second pain requires less frequent stimulation in fibromyalgia patients compared to normal controls. Pain 110:689\u2013696 10.1016\/j.pain.2004.05.009, 15288410","journal-title":"Pain"},{"key":"151_CR28","doi-asserted-by":"publisher","first-page":"S157","DOI":"10.1007\/s10072-004-0277-5","volume":"25","author":"J Schoenen","year":"2004","unstructured":"Schoenen J (2004) Tension-type headache and fibromyalgia: what\u2019s common, what\u2019s different? Neurol Sci 25:S157\u2013S159 10.1007\/s10072-004-0277-5, 15549528","journal-title":"Neurol Sci"},{"issue":"Suppl 21","key":"151_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1177\/0333102498018S2111","volume":"18","author":"M Nicolodi","year":"1998","unstructured":"Nicolodi M, Sicuteri F (1998) Fibromyalgia and headache. Failure of serotonergic analgesia and N-methyl-D-aspartate-mediated neuronal plasticity: their common clues. Cephalalgia 18(Suppl 21):41\u201344 9533670","journal-title":"Cephalalgia"},{"key":"151_CR30","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/j.1468-2982.2006.01150.x","volume":"26","author":"S Ashina","year":"2006","unstructured":"Ashina S, Bendtsen L, Ashina M, Magerl W, Jensen R (2006) Generalized hyperalgesia in patients with chronic tension-type headache. Cephalalgia 26:940\u2013948 10.1111\/j.1468-2982.2006.01150.x, 1:STN:280:DC%2BD28vmsVajuw%3D%3D, 16886930","journal-title":"Cephalalgia"},{"key":"151_CR31","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/WCO.0b013e3282fee843","volume":"21","author":"A Mett","year":"2008","unstructured":"Mett A, Tfelt-Hansen P (2008) Acute migraine therapy: recent evidence from randomized comparative trials. Curr Opin Neurol 21:331\u2013337 10.1097\/WCO.0b013e3282fee843, 1:CAS:528:DC%2BD1cXntlSmtbs%3D, 18451718","journal-title":"Curr Opin Neurol"},{"key":"151_CR32","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1526-4610.2008.01064.x","volume":"48","author":"P Tfelt-Hansen","year":"2008","unstructured":"Tfelt-Hansen P (2008) Triptans vs other drugs for acute migraine. Are there differences in efficacy? A comment. Headache 48:601\u2013605 10.1111\/j.1526-4610.2008.01064.x, 18377382","journal-title":"Headache"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10194-009-0151-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10194-009-0151-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10194-009-0151-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10194-009-0151-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T03:53:09Z","timestamp":1739332389000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1007\/s10194-009-0151-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,15]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["151"],"URL":"https:\/\/doi.org\/10.1007\/s10194-009-0151-1","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,15]]}}}